| Factors associated with age disparities among cancer clinical trial participants EB Ludmir, W Mainwaring, TA Lin, AB Miller, A Jethanandani, ... JAMA oncology 5 (12), 1769-1773, 2019 | 187 | 2019 |
| Exploring applications of radiomics in magnetic resonance imaging of head and neck cancer: a systematic review A Jethanandani, TA Lin, S Volpe, H Elhalawani, ASR Mohamed, P Yang, ... Frontiers in oncology 8, 131, 2018 | 91 | 2018 |
| Machine learning applications in head and neck radiation oncology: lessons from open-source radiomics challenges H Elhalawani, TA Lin, S Volpe, ASR Mohamed, AL White, J Zafereo, ... Frontiers in oncology 8, 294, 2018 | 42* | 2018 |
| Racial and ethnic disparities among participants in US-based phase 3 randomized cancer clinical trials SR Grant, TA Lin, AB Miller, W Mainwaring, AF Espinoza, A Jethanandani, ... JNCI Cancer Spectrum 4 (5), pkaa060, 2020 | 40 | 2020 |
| Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials D Pasalic, GJ McGinnis, CD Fuller, AJ Grossberg, V Verma, ... European Journal of Cancer 136, 176-185, 2020 | 39 | 2020 |
| Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma H Elhalawani, ASR Mohamed, B Elgohari, TA Lin, AG Sikora, SY Lai, ... BMC cancer 20, 1-12, 2020 | 32 | 2020 |
| Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation J Heukelom, ME Kantor, ASR Mohamed, H Elhalawani, E Kocak-Uzel, ... Radiotherapy and Oncology 142, 100-106, 2020 | 31 | 2020 |
| Women’s representation among lead investigators of clinical trials in oncology EB Ludmir, W Mainwaring, AB Miller, TA Lin, A Jethanandani, ... JAMA oncology 5 (10), 1501-1502, 2019 | 29 | 2019 |
| Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials EB Ludmir, IM Subbiah, W Mainwaring, AB Miller, TA Lin, A Jethanandani, ... Journal of geriatric oncology 11 (3), 451-454, 2020 | 28 | 2020 |
| Radiographic retropharyngeal lymph node involvement in HPV‐associated oropharyngeal carcinoma: patterns of involvement and impact on patient outcomes TA Lin, AS Garden, H Elhalawani, B Elgohari, A Jethanandani, SP Ng, ... Cancer 125 (9), 1536-1546, 2019 | 23 | 2019 |
| Exclusion of patients with brain metastases from cancer clinical trials RR Patel, V Verma, AB Miller, TA Lin, A Jethanandani, AF Espinoza, ... Neuro-oncology 22 (4), 577-579, 2020 | 22 | 2020 |
| Performance status restriction in phase III cancer clinical trials J Abi Jaoude, R Kouzy, W Mainwaring, TA Lin, AB Miller, A Jethanandani, ... Journal of the National Comprehensive Cancer Network 18 (10), 1322-1326, 2020 | 20 | 2020 |
| Timing of local therapy affects survival in Ewing sarcoma TA Lin, EB Ludmir, KP Liao, MF McAleer, DR Grosshans, SL McGovern, ... International Journal of Radiation Oncology* Biology* Physics 104 (1), 127-136, 2019 | 20 | 2019 |
| Exclusion of men from randomized phase III breast cancer clinical trials KL Corrigan, W Mainwaring, AB Miller, TA Lin, A Jethanandani, ... The Oncologist 25 (6), e990-e992, 2020 | 19 | 2020 |
| Sex-based disparities among cancer clinical trial participants EB Ludmir, CD Fuller, S Moningi, W Mainwaring, TA Lin, AB Miller, ... JNCI: Journal of the National Cancer Institute 112 (2), 211-213, 2020 | 14 | 2020 |
| Exclusion of older adults in COVID-19 clinical trials J Abi Jaoude, R Kouzy, MB El Alam, V Subbiah, CM Taniguchi, EB Ludmir, ... Mayo Clinic Proceedings 95 (10), 2293, 2020 | 12 | 2020 |
| Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions TA Lin, JS Lin, T Wagner, N Pham Journal of gastrointestinal oncology 9 (5), 858, 2018 | 12 | 2018 |
| Non-English language validation of patient-reported outcome measures in cancer clinical trials SR Grant, SS Noticewala, W Mainwaring, TA Lin, AB Miller, ... Supportive Care in Cancer 28, 2503-2505, 2020 | 11 | 2020 |
| Reporting and exclusion of sexual and gender minorities in cancer clinical trials. EB Ludmir, AF Espinoza, A Jethanandani, TA Lin, W Mainwaring, ... International journal of cancer 146 (8), 2020 | 11 | 2020 |
| Food and Drug Administration approvals in phase 3 cancer clinical trials J Abi Jaoude, R Kouzy, M Ghabach, R Patel, D Pasalic, E Ghossain, ... BMC cancer 21 (1), 695, 2021 | 10 | 2021 |
Clifton David FullerUniversity of Texas MD Anderson Cancer Center/Graduate School of Biomedical SciencesAdresse e-mail validée de mdanderson.org
